Maximize on Your Brand's Visibility
The non-opioid pain therapeutics landscape is entering a pivotal moment. After decades of limited clinical progress, recent regulatory approvals, novel targets, and translational breakthroughs have created a rapidly expanding pipeline.
The 2026 summit placed many organizations at the intersection of R&D leadership, innovation, and commercial opportunity.
Developing effective non-opioid therapies remains scientifically and clinically challenging. Key hurdles include translating preclinical efficacy into humans, managing the heterogeneity of chronic pain populations, mitigating high placebo responses in trials, and addressing variability in patient-reported outcomes.
Partnership would allow you to demonstrate how your solutions - whether advanced biomarker assays, PRO platforms, innovative novel translational, or trial optimization technologies - directly address these challenges and accelerate clinical progression.
Conference was not overwhelmingly large which allowed for great networking.
Abbvie
(World CNS Series)
What You Missed
Meeting New Clients
With the pain therapeutics field rapidly expanding, this summit attracted a globally represented audience of biopharma leaders and clinical decision-makers. Dedicated networking opportunities and interactive sessions provided direct access to these experts to build relationships and establish their brands as trusted partners in advancing next-generation pain therapies.
Gaining Actionable Market Intelligence
With emerging targets, novel mechanisms, and evolving clinical strategies, the pain space is rapidly shifting. Dedicated networking sessions and interactive discussions provided direct insight into unmet needs, trial priorities, and strategic considerations shaping non-opioid pain programs.
Showcasing Your Solutions
Our partners demonstrated how their technologies, platforms, or services accelerate development, improve trial outcomes, and address complex translational challenges. By positioning their solutions alongside leading biopharma companies and cutting-edge innovations, they gained visibility, credibility, and strategic alignment in a rapidly growing market poised for clinical and commercial impact.
Key Services & Solutions
Our attendees from non-opioid pain therapeutics were looking for service and solution providers with capabilities in the below areas but not limited to:
1
Support with Placebo-Controlled Standardised Studies
2
Translational Human-Pain Models
3
Advanced Electrophysiology for Preclinical Accuracy
4
Biomarker Discovery Platforms for Novel Targeting Mechanisms
2026 Audience Composition
Company Type
Attendee Seniority
Attending Companies Included
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us at sponsor@hansonwade.com if you would like to get involved and discuss a bespoke package suited to your needs.
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.